semaglutide effects on heart Efficacy and safety of in patients with failure with preserved ejection fraction and obesity - Rehman - 2024 - Clinical Cardiology Semaglutide and Cardiovascular Health |

Retatrutide (Triple-agonist GLP-1/GIP/Glucagon) Starting at: $495 Weight loss medicine is evolving quickly and Retatrutide is one of the most closely watched investigational medications in the next generation of metabolic therapies

evaluated 55 patients and found an overall incidence of postoperative shivering of 36%

Wilkinson L, Verhoog NJD, Louw A

(8.3) Geriatrics: Higher incidence of adverse reactions related to hypotension

While they have demonstrated some anti-inflammatory effects in research settings, newer agents generally produce greater weight loss and may therefore have more pronounced effects on inflammation-related markers